JPRN-UMIN000017652
Completed
N/A
A phase II study of preoperative chemotherapy cosisting docetaxel, oxaliplatin and S-1 for the clinical Stage III gastric cancer - A phase II study of preoperative DOS for cStage III gastric cancer
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine0 sites50 target enrollmentMay 22, 2015
ConditionsGastric cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Gastric cancer
- Sponsor
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. 2\) Past history of severe hypersensitivity to drugs. 3\) Active infection. 4\) Severe complications (interstitial pneumonia, pulmonary fibrosis, renal failure, liver failure, heart failure, uncontrollable diabetes millutus and Uncontrollable hypertension) 5\) Peripheral motor neuropathy or peripheral sensory neuropathy by any reason. 6\) Edema of limbs and trunk by any reason. 7\) Continuous systemic steroid therapy. 8\) Under treatment with flucytosine, phenytoin, or warfarin. 9\) Abnormal electrocardiogram or severe cardiovascular disease. 10\) Severe diarrhea. 11\) Positive HBs antigen. 12\) Pregnant women, or women with the possibility of the pregnancy and men who want let to pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II Trial of Preoperative Chemotherapy and Bevacizumab in Patients With Stage IIIA Non-Squamous Non-Small Cell Lung Canceron-squamous, Non-small cell lung cancerJPRN-UMIN000004487Osaka International Cancer Institute30
Not Yet Recruiting
N/A
A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancerJPRN-UMIN000016518Meiwa Hospital60
Recruiting
Phase 2
Phase II study of perioperative chemotherapy (preoperative XELOX+Bevacizumab/ postoperative XELOX) in patients with locally advanced rectal cancerRectal cancerJPRN-UMIN000013000Sano Hospital Masahito Kotaka, MD50
Recruiting
N/A
A phase 2 clinical trial of preoperative chemoradiation therapy for locally advanced low rectal cancer with limited radiation field to the lesser pelvisocally advanced low rectal cancerJPRN-UMIN000013383Gunma University Graduate School of Medicine52
Completed
N/A
A Phase II trial of preoperative chemoradiation therapy with S-1 for locally-advanced rectal cancerlocally advanced rectal cancer (T3-4, N0-2, M0)JPRN-UMIN000015530Department of Surgery, Miyagi Cancer Center15